The strategy of intermittent triple therapy for people living with HIV was validated in France following the randomized clinical trial QUATUOR. There is little data in real life, as shown in the meta-analysis of Parienti JJ et al. Currently this strategy is proposed by some teams in France, but is not recommended internationally. The research hypothesis is that intermittent treatment is an effective and safe option in a therapeutic lightening strategy in people living with HIV People living with HIV adults followed in Strasbourg who have benefited from intermittent treatment The expected results will consist of an improvement in knowledge on the efficacy and tolerance of this therapeutic strategy.
Study Type
OBSERVATIONAL
Enrollment
200
Service Le Trait d'Union - CHU de Strasbourg - France
Strasbourg, France
Evaluation of HIV viral load
Time frame: 48 weeks after reduction of the HIV viral load
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.